In February, manufacturer Amgen announced that the FDA approved Parsabiv (etelcalcetide) for secondary hyperparathyroidism in patients with chronic kidney disease (CKD) on hemodialysis. Secondary Hyperparathyroidism is a condition that lowers calcium levels, causing your parathyroid glands to overproduce the parathyroid hormone. This can cause cardiovascular, neurological and immune system complications. Secondary hyperparathyroidism is especially seen in…
FDA Approves Generic Dexilant for Heartburn
Heartburn, also known as acid reflux or gastroesophageal reflux disease (GERD), is a digestive disease in which stomach acid of bile irritates the food pipe lining. These days, many heartburn medications are conveniently available over-the-counter. However, some of these medications still require a prescription from your doctor. Common treatments include medications like Nexium (esomeprazole), Protonix…
These 10 Drugs Could Harm Your Eyes
Copyright ©2015 GoodRx, Inc. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data…
Make Sure You Check These 5 Things on Every New Prescription
Although there are many ways your doctor can get your prescription to the pharmacy (phone in, fax, electronically, etc.), many doctors will still write out a paper prescription. If your doctor hands you a prescription, there are a few important things you should know and/or look for. 1. Is your name correct? Believe it or…
Another Cheaper EpiPen Alternative Just Got FDA Approval
Watch out EpiPen there’s (another) new kid on the block. On June 15, 2017, Adamis Pharmaceuticals received FDA approval for Symjepi, their new epinephrine injection. Symjepi joins Adrenaclick, Auvi-Q, and others as an alternative to the expensive treatment for severe allergic reactions. Adamis also anticipates a low cost for the life-saving medication. As you may…
Updated FDA Safety Alert: Invokana and Invokamet for Diabetes
On May 16th, 2017, the FDA issued an update on canagliflozin-containing medications, like Invokana and Invokamet, as part of a year-long ongoing review. This update is the result of new data from the CANVAS and CANVAS-R clinical trials. This research showed that leg and foot amputations occurred two times more often in patients treated with…
10 Albuterol Inhaler Side Effects to Watch Out For
Copyright ©2015 GoodRx, Inc. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data…
FDA Recalls Eliquis Due to Mislabeling
Manufacturer Bristol-Myers Squibb has issued a voluntary recall of Eliquis, a commonly prescribed blood thinner. Eliquis can be used to reduce the risk of stroke due to atrial fibrillation, treat blood clots, prevent future blood clots, and decrease the risk of blood clots following surgery. This is a class 1 recall, the most serious type…
Should You Be Subscribing to Have Your Test Strips Delivered?
If you have diabetes, you’re probably no stranger to checking your own blood sugar with a little portable device known as a glucose meter. For those of you who don’t—to get a blood sugar reading, glucose meters require a small amount of blood to be placed on a test strip, and you need a new…
New Report Discusses Deaths Related to Actemra
Back in 2010, Actemra (tocilizumab) was approved by the FDA to treat rheumatoid arthritis (RA), an inflammatory condition affecting joints. At the time, with over 1.5 million Americans suffering from RA, Actemra‘s release was promising for many doctors and patients. Actemra is a first-in-class drug, meaning it works in a new and unique way to to treat…